SOURCES SOUGHT
69 -- Notice of Intent HIV-1 LAg- Avidia EIA
- Notice Date
- 10/31/2011
- Notice Type
- Sources Sought
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2012-05908
- Archive Date
- 11/22/2011
- Point of Contact
- Tayaria L Smith, Phone: 7704882797
- E-Mail Address
-
gqq4@cdc.gov
(gqq4@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- Notice of Intent Reference: # 2012-05098 The Division of Global AIDS Program Centers for Disease Control and Prevention intends to award a sole source, firm fixed price contract, in accordance with FAR 13, using simplified acquisition procedures, to Sedia Biosciences, 4900 NE 122nd Ave, Portland, OR, 97230. Sedia Biosciences will provide HIV and BED kits-an enzyme immunoassay based on technology licensed from the US CDC for population estimates of HIV-1 incidence. Sedia Biosciences appear to be the only vendor that manufactures and sells these HIV immunoassays and Lag Avidity assay kits. No Request for Quotes (RFQ) will be issued based upon this Notice of Intent. This advertisement ends in 7 days accordance with FAR 5.203 (A) (1).Any interested companies are welcome to submit their ability to provide these kits via e-mail, gqq4@cdc.gov. Please include reference number (2012-05098). Please respond by Monday, November 7, 2011.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2012-05908/listing.html)
- Record
- SN02615266-W 20111102/111031234108-0f005f0366a438cf5837a0a82cc8e11a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |